Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/sciences-humaines-et-sociales/melanoma/descriptif_3489027
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3489027

Melanoma, 1st ed. 2019

Langue : Anglais

Coordonnateurs : Fisher David E., Bastian Boris C.

Couverture de l’ouvrage Melanoma
Melanoma is a cutting edge, comprehensive reference work on the topic of melanoma. The overarching goal is to provide detailed scholarly information which broadly covers all aspects of the clinical presentation and management of the disease, as well as the biological and scientific understanding of its pathogenesis and treatment. Key topics highlighted include recent breakthroughs in molecular diagnostics, breakthroughs in targeted therapeutic approaches, overviews of signaling and transcriptional pathways, and important controversies such as screening, early diagnosis, sentinel node biopsy, and prevention strategies. In all, the volume provides a cutting edge and comprehensive presentation of the field of melanoma, written by a team of internationally renowned thought-leaders.
Acral Melanoma.- Adjuvant Therapy.- Animal Models of Melanoma.- Biology of Melanoma Metastasis.- Care of the Melanoma Patient.- Clinical Management of Primary Cutaneous Melanoma.- Combinatorial Approach to Treatment of Melanoma.- Developmental Biology of Melanocytes.- Epidemiology of Melanocytic Neoplasia.- Genetic Counseling.- Imaging Melanoma.- Immunotherapy (Clinical).- Inherited Contributions to Melanoma Risk.- Key Signaling Pathways in Normal and Neoplastic Melanocytes

David E. Fisher, MD, PhD, is chief of the Massachusetts General Hospital Department of Dermatology. He also serves as director of Mass General’s Cutaneous Biology Research Center, director of the Melanoma Center and as Chair of the MGH Executive Committee on Research. A professor of dermatology and of pediatrics at Harvard Medical School, Dr. Fisher came to Mass General from the Dana-Farber Cancer Institute, where he previously directed the melanoma program. Dr. Fisher’s research has focused on understanding the molecular and genetic events which underlie formation of melanoma as well as skin pigmentation. As a clinician, he has worked to translate these understandings into advances in diagnosis, treatment and prevention of human diseases related to the skin and associated disorders.

A graduate of Swarthmore College with a degree in biology and chemistry, Dr. Fisher is also an accomplished concert cellist and graduated from the Curtis Institute of Music in Philadelphia. He received his doctorate under Nobel Laureate Gunter Blobel and Henry Kunkel at Rockefeller University and his medical degree at Cornell University Medical College. Dr. Fisher’s specialty training in Medicine, Pediatrics and Oncology were carried out at Dana-Farber Cancer Institute, Boston Children’s Hospital, and Brigham and Women’s Hospital, Harvard Medical School. His research contributions include elucidation of the pathway through which UV radiation induces pigmentation, identification of MITF as master transcriptional regulator in melanocytes and melanoma oncogene, novel approaches to melanoma treatment and prevention, and discovery of the link between ultraviolet radiation and addictive behaviors.

Boris C. Bastian, MD, received his medical degree from the University of Munich, Germany. He completed his residency in dermatology at the University of Würzburg, Germany. He did a post-doctoral fellowship at the Cancer Genetics Program at the University of California,

Cutting-edge and comprehensive presentation of the field of melanoma
Written by a team of internationally renowned thought-leaders
Topics include recent breakthroughs in molecular diagnostics, breakthroughs in targeted therapeutic approaches, overviews of signaling and transcriptional pathways, and important controversies such as screening, early diagnosis, sentinel node biopsy, and prevention strategies

Date de parution :

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

Prix indicatif 1075,05 €

Ajouter au panier

Date de parution :

17.8x25.4 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

738,49 €

Ajouter au panier
En continuant à naviguer, vous autorisez Lavoisier à déposer des cookies à des fins de mesure d'audience. Pour en savoir plus et paramétrer les cookies, rendez-vous sur la page Confidentialité & Sécurité.
FERMER